Lung Ultrasound Guided Fluid Management Protocol for the Critically Ill Patient: study protocol for a multi-centre randomized controlled trial

Abstract

Background In routine intensive care unit (ICU) practice, fluids are often administered without a safety limit, which may lead to fluid overload and decreased survival. Recently, B-lines score (BLS) has been validated as a lung ultrasound (LUS) quantification of pulmonary congestion. This suggests that LUS may provide a safety threshold to conduct fluid therapy and to avoid overhydration. However, there is no randomized study to test the utility of LUS in guiding fluid management in ICU patients by using a pre-specified BLS cut-off value as a threshold for fluid removal. Methods LUS Guided Fluid Management Protocol for the Critically Ill Patient is a prospective, multi-centre, randomized controlled trial. Five hundred ICU patients will be randomly assigned in a 1:1 ratio, to protocolized LUS-based fluid management or usual care. The trial intervention will start on ICU admission and will consist in daily assessment of BLS and triggered evacuation of excessive fluids with loop diuretics (Furosemide) when BLS ≥ 15. If rebalancing volume status with diuretics fails, forced evacuation by ultrafiltration will be used. The main endpoint is death from all causes at 28 days from randomization. The secondary outcomes are presence and time-course evolution of organ dysfunctions, ICU- and hospital length of stay, all-cause mortality at 90 days, and health economics data. Discussion If study results will show that LUS guided fluid management protocol improves outcome in ICU patients, it will be the base for other studies to refine this protocol or track those categories of critically ill patients to whom it may bring maximum benefits. Trial registration ClinicalTrials.gov, NCT03393065 . Registered on 8 January 2018. Electronic supplementary material The online version of this article (10.1186/s13063-019-3345-0) contains supplementary material, which is available to authorized users.

Lung ultrasonography findings of coronavirus disease 2019 patients: Comparison between primary and secondary regions of China

“…Internal lesions can only be detected when lung water increases and spreads to surrounding areas or when consolidation occurs. However, ultrasonography has been widely used in clinical practice in recent years as a noninvasive and rapid examination method, especially for severe pneumonia among adults and children 10–12 . As the chest plain radiograph and CT of COVID‐19 cases show bilateral involvement and peripheral distribution, the pathology is mainly characterized by exudation 1,13–16 ; bedside ultrasonography has played an important role in the diagnosis and treatment of COVID‐19, and our research results have confirmed this point.…”

The impact of lung ultrasound on clinical-decision making across departments: a systematic review

“…Similarly, wrongful interpretation of ultrasound accompanied by unwarranted change of management may have undesired effects. Currently, several trials are either underway or recently published that may potentially provide higher quality evidence [ 36 – 38 ].…”

Effects of Lung Ultrasonography-Guided Management on Cumulative Fluid Balance and Other Clinical Outcomes: A Systematic Review

“…Considering the pathophysiologic rationale behind normalizing interstitial fluid and circulating volume, and lung ultrasonography's ability to affect these parameters, we believe that larger, well-designed trials might be able to identify important effects on clinical outcomes. There are currently several ongoing trials on lung ultrasonography-guided management that may provide further and higher quality of evidence (Bail on et al 2019;Russell et al 2019;Rusu et al 2019).…”